Ascendis Pharma A/S (ASND)
NASDAQ·Healthcare·Biotechnology
$246.14
—
Mkt Cap $14.73B
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (55 analysts)
$320.36
Range $273.00 – $345.00
Implied Upside
+30.2%
Consensus $320.36 vs current $246.14
NASDAQ·Healthcare·Biotechnology
$246.14
—
Mkt Cap $14.73B
Buy
3
Hold
0
Sell
0
Price Target (55 analysts)
$320.36
Range $273.00 – $345.00
+30.2%
Consensus $320.36 vs current $246.14